ES2077017T3 - Vacuna contra el virus de la bronquitis infecciosa. - Google Patents

Vacuna contra el virus de la bronquitis infecciosa.

Info

Publication number
ES2077017T3
ES2077017T3 ES90202667T ES90202667T ES2077017T3 ES 2077017 T3 ES2077017 T3 ES 2077017T3 ES 90202667 T ES90202667 T ES 90202667T ES 90202667 T ES90202667 T ES 90202667T ES 2077017 T3 ES2077017 T3 ES 2077017T3
Authority
ES
Spain
Prior art keywords
polypeptide
vaccine against
infectious bronchitis
against infectious
bronchitis virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90202667T
Other languages
English (en)
Inventor
Paulus Jacobus An Sondermeijer
Johannes Antonius Jo Claessens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2077017T3 publication Critical patent/ES2077017T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA INVENCION ES CONCERNIENTE A UNA POLIPEPTIDA QUE CONTIENE LA SECUENCIA AMINO ACIDA DE LA POLIPEPTIDA DE LA PROTEINA ASOCIADA A UNA CEPA DE VBI PERTENECIENTE AL SEROTIPO ARKANSAS, O A UN FRAGMENTO ORGANICO DE ELLA. TAL POLIPEPTIDA SE PUEDE USAR PARA LA INMUNIZACION DE PAJAROS CONTRA INFECCIONES DE VBI. LA INVENCION TAMBIEN ES RELATIVA A UNA SECUENCIA DE ACIDO NUCLEICO CODIFICANDO TAL POLIPEPTIDA. DICHA SECUENCIA DE ACIDO NUCLEICO SE USA ESPECIALMENTE PARA LA PREPARACION DE VACUNAS VECTORIALES.
ES90202667T 1989-10-20 1990-10-08 Vacuna contra el virus de la bronquitis infecciosa. Expired - Lifetime ES2077017T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42479389A 1989-10-20 1989-10-20

Publications (1)

Publication Number Publication Date
ES2077017T3 true ES2077017T3 (es) 1995-11-16

Family

ID=23683895

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90202667T Expired - Lifetime ES2077017T3 (es) 1989-10-20 1990-10-08 Vacuna contra el virus de la bronquitis infecciosa.

Country Status (10)

Country Link
EP (1) EP0423869B1 (es)
JP (1) JPH03228680A (es)
KR (1) KR910008130A (es)
CN (1) CN1053642A (es)
CA (1) CA2028045A1 (es)
DE (1) DE69020848D1 (es)
ES (1) ES2077017T3 (es)
HU (1) HUT56136A (es)
NZ (1) NZ235742A (es)
ZA (1) ZA908189B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104382A0 (en) * 1992-01-17 1993-05-13 Solvay Animal Health Inc Vaccine containing acemannan as an adjuvant
GB9203509D0 (en) * 1992-02-19 1992-04-08 British Tech Group Ibv spike protein(2)
US6913751B2 (en) 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
US7314715B2 (en) 2001-06-14 2008-01-01 Schering-Plough Animal Health Corporation Recombinant avian herpesvirus useful in vaccine production
CN103642759B (zh) * 2013-11-15 2016-01-27 中国农业科学院兰州兽医研究所 嵌合ibv 4/91株纤突蛋白膜外区基因片段的重组传染性支气管炎病毒及其构建方法和应用
CN109985235A (zh) * 2019-01-29 2019-07-09 苏州世诺生物技术有限公司 鸡传染性支气管炎基因工程亚单位疫苗
US20240000920A1 (en) 2020-11-12 2024-01-04 Intervet Inc. Recombinant vectors encoding chimeric coronavirus spike proteins and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650289T2 (de) * 1985-03-29 1995-08-10 British Tech Group Spike-protein des virus der infektiösen bronchitis.
DK515286A (da) * 1985-10-31 1987-05-01 Duphar Int Res Antigent aktive proteiner og peptider og vacciner mod infektioes bronchitis virus (ibv)
JP2779447B2 (ja) * 1988-03-20 1998-07-23 財団法人阪大微生物病研究会 弱毒マレック病ウイルス・ベクターを用いる組換え遺伝子作成法、及び該ウイルスの組換え体
US5093258A (en) * 1988-08-26 1992-03-03 Therion Biologics Corporation Recombinant fowlpox virus and recombination vector

Also Published As

Publication number Publication date
CN1053642A (zh) 1991-08-07
KR910008130A (ko) 1991-05-30
HU906509D0 (en) 1991-04-29
EP0423869A1 (en) 1991-04-24
ZA908189B (en) 1991-08-28
EP0423869B1 (en) 1995-07-12
HUT56136A (en) 1991-07-29
NZ235742A (en) 1992-09-25
CA2028045A1 (en) 1991-04-21
JPH03228680A (ja) 1991-10-09
DE69020848D1 (de) 1995-08-17

Similar Documents

Publication Publication Date Title
EA202192570A1 (ru) Иммуногенные композиции и вакцины, содержащие пептиды и белки вируса африканской чумы свиней, и их применение
ES2059565T3 (es) Virus mva de la vacuna, recombinante.
WO2011054011A3 (en) Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
MX9207113A (es) Fragmento de adn, peptido que comprende una proteina superficial ha de un virus de gripe a y vacuna que comprende tal peptido.
PE20011217A1 (es) Composicion farmaceutica para modulacion inmunologica y preparacion de vacunas
AR003425A1 (es) Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de poxvirus para preparar una vacuna util para evitar o para disminuir la enfermedad causada por el virus de inmunodeficiencia felina (fiv)
DK0596979T3 (da) Rekombinante nucleinsyrer fra plantevirus
EA200100425A1 (ru) Новые способы терапевтической вакцинации
NO329875B1 (no) Isolert DNA-sekvens som koder for svinereproduktive- og respiratoriske syndromvirus (PRRSV), en sammensetning omfattende polypeptidene kodet av denne, en sammensetning for indusering av antistoffer mot PRRSV, anvendelse av sammensetning for fremstilling av vaksine og fremgangsmate for a skille PRRSV-stamme ISU-55 fra andre PRRSV-stammer.
EP0090886A3 (en) Stabilization of influenza virus vaccine
AR067658A2 (es) Un polipeptido inmunogenico, un polinucleotido que lo codifica , las composiciones farmaceuticas que contienen dichos polipeptidos y polinucleotido, los vectores de xpresion, vacunas, un metodo para la preparacion de dicho polipeptido y una celula huesped aislada que expresa dicho polipeptido
ES2127294T3 (es) Vacunas del virus de la inmunodeficiencia anti-felino (fiv).
ATE328073T1 (de) Ehrlichia canis protein
ES2077017T3 (es) Vacuna contra el virus de la bronquitis infecciosa.
ES2039239T3 (es) Vacuna contra el virus varicela-zoster.
DE60236579D1 (de) Bakteriophagenvermittelte impfung
MX2022001028A (es) Vacuna de la fiebre porcina africana.
BR9812240A (pt) Proteìna g alterada ou polipeptìdeo do rsv, uso da mesma, molécula de ácido nucleico codificando uma proteìna g alterada ou um polipeptìdeo do rsv, construção do ácido nucleico, célula hospedeira recombinante, processos de produção de uma proteìna g alterada ou polipeptìdeo do rsv composição imunogênica, de indução de uma resposta imune em um vertebrado, de inibir a indução do aumento da doença após a vacinação e subsequente infecção de um vertebrado com o rsv e de imunização de um vertebrado contra o rsv, composição de vacina, vacina, e, composição imunogênica
AR051853A1 (es) Vacuna para aumentar el crecimiento basada en epitopes neutralizantes
AR036793A1 (es) Vacunas de acido nucleico que utilizan acidos nucleicos que codifican un antigeno de tumor con un acido nucleico que codifica una citoquina como adyuvante
FR2828405B1 (fr) Vaccin anti-coronavirus
ES2063897T5 (es) Vacuna contra el virus del colera porcino y diagnostico.
AR009365A1 (es) Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno
AR241713A1 (es) Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe.
ES2059305T5 (es) Proteina del virus de la seudorrabia.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 423869

Country of ref document: ES